George M. Milne Jr.

CIK: 0001179552

Transaction Breakdown

Open Market Buys (P)1 (16.7%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AMLX

Amylyx Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

AMLX
Amylyx Pharmaceuticals, Inc.
Oct 5, 2026
Sale(S)
Direct
30K shares at avg. $27.70$831K
AMLX
Amylyx Pharmaceuticals, Inc.
Jun 4, 2026
Award(A)
Stock Option (right to buy)
Direct
24.4K shares-
AMLX
Amylyx Pharmaceuticals, Inc.
Jan 12, 2026
Gift(G)
Direct
17.8K shares-
AMLX
Amylyx Pharmaceuticals, Inc.
Jun 5, 2025
Award(A)
Stock Option (right to buy)
Direct
25K shares-
AMLX
Amylyx Pharmaceuticals, Inc.
Jan 24, 2025
Gift(G)
Direct
27.9K shares-
AMLX
Amylyx Pharmaceuticals, Inc.
Sep 3, 2024
Purchase(P)
Direct
100K shares at avg. $2.20$220K

		Type	Shares	Price		Ownership
Oct 5, 2026	AMLX Amylyx Pharmaceuticals, Inc.	Sale(S)	30,000	$27.70	$830,904	Direct
Jun 4, 2026	AMLX Amylyx Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	24,372	-	-	Direct
Jan 12, 2026	AMLX Amylyx Pharmaceuticals, Inc.	Gift(G)	17,780	-	$0	Direct
Jun 5, 2025	AMLX Amylyx Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	25,000	-	-	Direct
Jan 24, 2025	AMLX Amylyx Pharmaceuticals, Inc.	Gift(G)	27,910	-	$0	Direct
Sep 3, 2024	AMLX Amylyx Pharmaceuticals, Inc.	Purchase(P)	100,000	$2.20	$219,800	Direct

1-6 of 6 transactions

About MILNE GEORGE M JR

MILNE GEORGE M JR (SEC CIK 0001179552) files insider reports with the SEC as Director of Amylyx Pharmaceuticals, Inc. (AMLX).

Signal8 holds 6 ownership filings by MILNE GEORGE M JR, all Form 4s, filed between Sep 5, 2024 and Oct 7, 2026. Those filings report 6 transactions, from Sep 3, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MILNE GEORGE M JR's filings is in CAMBRIDGE, MA.

Recent filings by MILNE GEORGE M JR

Oct 5, 2026: Open-market sale of AMLX shares (Form 4, code S).
Jun 4, 2026: Grant or award of AMLX derivative securities (Form 4, code A).
Jan 12, 2026: Gift of AMLX shares (Form 4, code G).
Jun 5, 2025: Grant or award of AMLX derivative securities (Form 4, code A).
Jan 24, 2025: Gift of AMLX shares (Form 4, code G).

Other insiders filing for Amylyx Pharmaceuticals, Inc. (AMLX)

Bedrosian Camille L, Chief Medical Officer
FRATES JAMES M, Chief Financial Officer
Mazzariello Gina, Chief Legal Officer
Klee Justin B., Co-Chief Executive Officer
Cohen Joshua B, Co-Chief Executive Officer
Firestone Karen, Director

How to read Form 4 transaction codes